{
  "title": "M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders",
  "content": "﻿﻿<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nGeneral Information on Neurological and Convulsive Disorders\n2\nPeripheral Nerves\n3\nMigraine Headaches\n1\n.\nGeneral Information on Neurological and Convulsive Disorders\nIntroduction\nThis topic contains general information about neurological and convulsive disorders, including\nconsiderations in service connection (SC) for neurological disorders\nidentifying epilepsy\nevaluating progressive spinal muscular atrophy\nother organic diseases of the nervous system under 38 CFR 3.309(a)\nSC of vertigo\n, and\nrequesting examinations for manifestations of central nervous system diseases\n.\nChange Date\nFebruary 26, 2025\nV.iii.12.A.1.a\n.\nConsiderations in SC for Neurological Disorders\nSee the table below for etiological considerations and manifestations involving specific neurological disorders.\nWhen ...\nThen ...\nconsidering questions of incurrence or aggravation in service\nbear in mind the etiology and clinical course of each separate disease.\nconsidering conditions of infectious origin\nconsider both the circumstances of infection and the incubation period.\ndetermining aggravation for conditions such as multiple sclerosis (MS), progressive muscular atrophy, and myasthenia gravis\nbe aware that increased symptomatology over a period of a few months may reflect natural progression of the disease.  Base determinations on the developed medical evidence of record.\nV.iii.12.A.1.b\n.\nIdentifying Epilepsy\nSeizures must be witnessed\nor\nverified by a physician to warrant service connection (SC) for epilepsy.  Verification may be by an electroencephalogram (EEG), which measures electrical activity in the brain.\nA physician does not have to witness an actual seizure before a diagnosis of epilepsy can be accepted for evaluation purposes.  Verification by a physician based upon factors other than observing an actual seizure is sufficient.\nReferences\n:  For more information on\nidentifying epilepsy, see\n38 CFR 4.121\n, and\npsychomotor epilepsy, see\n38 CFR 4.122\n.\nV.iii.12.A.1.c\n.\nEvaluating Progressive Spinal Muscular Atrophy\nProgressive muscular atrophy,\n38 CFR 4.124a, diagnostic code (DC) 8023\n, refers to progressive spinal muscular atrophy, which is a disease of the spinal cord.\nProgressive muscular atrophy is subject to presumptive SC under\n38 CFR 3.309(a)\nbecause it is an organic disease of the nervous system.\nV.iii.12.A.1.d\n.\nOther Organic Diseases of the Nervous System Under 38 CFR 3.309(a)\nFor purposes of establishing presumptive SC for a chronic disease under\n38 CFR 3.307\n, the term\nother organic diseases of the nervous system\nin\n38 CFR 3.309(a)\nincludes any commonly recognized neurological disease (such as may be found in a valid contemporary medical treatise), which is not otherwise specifically enumerated under\n38 CFR 3.309(a)\n.  This includes,\nbut is not limited to\n, the following conditions:\ncarpal tunnel syndrome\nmigraine headaches\nsensorineural hearing loss\ntinnitus\nglaucoma\nprogressive spinal muscular atrophy\ndiseases of the cranial nervous system\ncranial nerve conditions, and\nperipheral nerve conditions, such as peripheral neuropathy.\nImportant\n:  If there is uncertainty as to whether or not a claimed disability may be considered as an organic disease of the nervous system for purposes of\n38 CFR 3.309(a)\n, send the case to Compensation Service for guidance.\nReferences\n:  For more information on\npresumptive SC, see\nM21-1, Part V, Subpart ii, 2.B\nreferring a claim for an advisory opinion, see\nM21-1, Part X, Subpart v, 1.A.2\n, and\nestablishing SC for hearing loss and tinnitus, see\nM21-1, Part V, Subpart iii, 2.B\n.\nV.iii.12.A.1.e\n.\nSC of Vertigo\nCarefully consider the evidence of record when considering SC for vertigo.  Vertigo is generally considered a symptom of another disability such as traumatic brain injury (TBI), Meniere's disease, vestibular neuritis/labyrinthitis, MS, stroke or tumor.\nWhen the disability manifested by vertigo is adequately identified, SC should be established for that diagnosis rather than for \"vertigo.\"  However, SC can be established for \"vertigo\" in the absence of a known or established underlying etiology if there is\nan event in service (such as a nonspecific diagnosis of vertigo in service)\nvertigo present post service\na nexus establishing the vertigo post service is connected to the event in service, and\nthe condition is\nnot\nassociated with any other disease or injury.\nReferences\n:  For more information on\nevaluating vertigo as a symptom of TBI and the prohibition against evaluating vertigo separately from TBI, see\nM21-1, Part V, Subpart iii, 12.B.1.i\n, and\nprinciples related to SC, see\n38 CFR 3.303\n, and\nM21-1, Part V, Subpart ii, 2\n.\nV.iii.12.A.1.f\n.\nRequesting Examinations for Manifestations of Central Nervous System Diseases\nAll manifestations or residuals of a central nervous system disease under\n38 CFR 4.124a, DCs 8000-8025\n, must be examined using\nonly\nthe applicable disability benefits questionnaire (DBQ) for the primary or underlying central nervous system disease.  Do\nnot\nrequest a different DBQ specifically for any manifestations or residuals, as these are accounted for in the DBQ for the primary or underlying disease.\nNote\n:  This applies in all cases where an examination is needed for such manifestations or residuals, even if the primary or underlying central nervous system disease itself is not at issue in the associated claim.\nException\n:  When the disabling manifestation requires a specialist examination, as outlined in\nM21-1, Part IV, Subpart i, 2.A.1.g\n, request the specific DBQ for the condition requiring a specialist examination.\nExample\n:  Do\nnot\nrequest a\nPeripheral Nerves Conditions Disability Benefits Questionnaire\nfor evaluation of extremity tremor and weakness due to Parkinson’s disease.  Request\nonly\nthe\nParkinson’s Disease Disability Benefits Questionnaire\n, which includes an assessment for impairment of the extremities.\nReferences\n:  For more information on\nexamination requests, see\nM21-1, Part IV, Subpart i, 2.A\nprogressive neurological disorders, see\nM21-1, Part V, Subpart iii, 12.C\n, and\nDBQs, see the\nDBQ Switchboard\n.\n2\n.\nPeripheral Nerves\nIntroduction\nThis topic contains information on evaluating peripheral nerves, including\nregulations for evaluating peripheral nerves\n38 CFR 4.124a guidance on evaluating completely sensory peripheral nerve impairment\nassigning level of incomplete paralysis\n, neuritis, or neuralgia\nconsidering the complete findings when evaluating incomplete paralysis\nnerve branches of the lower extremities for which separate evaluations may be assigned\nassigning separate evaluations for lower extremity peripheral nerves\ndetermining individual nerves affected in the upper and lower extremities when evaluating disabilities\nelectromyography (EMG) and other tests for peripheral nerve conditions\napplying the amputation rule to peripheral nerve disabilities\n, and\nevaluating restless legs syndrome\n.\nChange Date\nApril 16, 2020\nV.iii.12.A.2.a\n.\nRegulations for Evaluating Peripheral Nerves\n38 CFR 4.124a, DCs 8510-8730\n, provides evaluation levels for complete paralysis, incomplete paralysis, neuritis, or neuralgia of peripheral nerves.\nAt the beginning of the DCs for the peripheral nerves, the regulation also states that “incomplete paralysis” anticipates substantially less impaired function than described for complete paralysis of the nerve.  When impairment is wholly sensory, the evaluation should be that specified for the\nmild\n, or at most, the\nmoderate\ndegree of incomplete paralysis for the nerve.\nThe regulations listed below also provide guidance on evaluating peripheral nerves.\n38 CFR 4.120\nprovides that when rating peripheral nerve injuries and residuals consider the relative impairment of motor function, trophic changes, and/or sensory disturbances.  Attention should be given to the site and character of the injury.\n38 CFR 4.123\nprovides several principles relating to peripheral nerves:\nNeuritis, characterized by loss of reflexes, muscle atrophy, sensory disturbances, and constant pain, is to be rated on the scale provided for injury of the nerve involved under the DCs and evaluations provided in\n38 CFR 4.124a\n.\nThe maximum evaluation for neuritis is the evaluation provided for\nsevere\nincomplete paralysis of the affected nerve.\nThe maximum evaluation that may be assigned for neuritis\nnot\ncharacterized by the organic changes referred to in the regulation\nis generally the evaluation level specified for\nmoderate\nincomplete paralysis of the nerve,\nbut\nis the evaluation level specified for\nmoderately severe\nimpairment when the affected nerve is the sciatic nerve.\n38 CFR 4.124\nprovides that the maximum evaluation for neuralgia, characterized usually by a dull and intermittent pain in the distribution of a nerve, should be the evaluation provided for\nmoderate\nincomplete paralysis of the nerve under the\napplicable DC.\nV.iii.12.A.2.b\n.\n38 CFR 4.124a Guidance on Evaluating Completely Sensory Peripheral Nerve Impairment\nIn cases where a peripheral nerve disability is only manifested by sensory impairment,\n38 CFR 4.124a\ndirects decision makers to assign the evaluation corresponding with the mild\nor at most\nthe moderate degree of impairment.\nTo make a choice between mild and moderate, consider the evidence of record and the following guidelines:\nThe mild level of evaluation would be more reasonably assigned when sensory symptoms are\nrecurrent but not continuous\nassigned a lower medical grade reflecting less impairment, and/or\naffecting a smaller area in the nerve distribution.\nReserve the moderate level of evaluation for the most significant and disabling cases of sensory-only involvement.  These are cases where the sensory symptoms are\ncontinuous\nassigned a higher medical grade reflecting greater impairment,\nand/or\naffecting a larger area in the nerve distribution.\nImportant\n:  This provision\ndoes not\nmean that if there is\nany\nimpairment that is non-sensory (or involves a non-sensory component) such as a reflex abnormality, weakness, or muscle atrophy, the disability must be evaluated as greater than moderate.  Significant and widespread sensory impairment may potentially indicate the same or even more disability than a case involving a minimally reduced or increased reflex or minimally reduced strength.\nReferences\n:  For more information on\nevaluating wholly sensory manifestations of peripheral nerves, see\nMiller v. Shulkin\n, 28 Vet.App. 376 (2017)\nconsidering the complete findings when evaluating incomplete paralysis, see\nM21-1, Part V, Subpart iii, 12.A.2.d\nthe importance of fully descriptive examinations and limitations from the disabling condition, see\n38 CFR 4.1\n, and\nthe importance of coordinating the evaluation with impairment of function based on sufficiently characteristic findings, see\n38 CFR 4.21\n.\nV.iii.12.A.2.c\n.\nAssigning Level of Incomplete Paralysis, Neuritis, or Neuralgia\nThe table below provides general guidelines for each level of incomplete paralysis of the upper and lower peripheral nerves.\nDegree of Incomplete Paralysis\nDescription\nMild\nAs this is the lowest level of evaluation for each nerve, this is the default assigned based on the symptoms, however slight, as long as they were sufficient to support a diagnosis of the peripheral nerve impairment for SC purposes.\nIn general, look for a disability limited to sensory deficits that are lower graded, less persistent, or affecting a small area.\nA very minimal reflex or motor abnormality potentially could also be consistent with mild incomplete paralysis.\nModerate﻿﻿\nModerate is the maximum evaluation reserved for the most significant cases of sensory-only impairment (\n38 CFR 4.124a\n).\nSymptoms will likely be described by the claimants and medically graded as significantly disabling.\nIn such cases a larger area in the nerve distribution may be affected by sensory symptoms.\nOther sign/symptom combinations that may fall into the moderate category include\ncombinations of significant sensory changes and reflex or motor changes of a lower degree, or\nmotor and/or reflex impairment such as weakness or diminished or hyperactive reflexes (with or without sensory impairment) graded as medically moderate.\nModerate is also the maximum evaluation that can be assigned for\nneuritis not characterized by organic changes referred to in\n38 CFR 4.123\n, or\nneuralgia characterized usually by a dull and intermittent pain in the distribution of a nerve (\n38 CFR 4.124\n).\nModerately Severe\nThe moderately severe evaluation level is only applicable for involvement of the sciatic nerve.\nThis is the maximum rating for sciatic nerve neuritis not characterized by the organic changes specified in\n38 CFR 4.123\n.\nMotor and/or reflex impairment (for example, weakness or diminished or hyperactive reflexes) at a grade reflecting a high level of limitation or disability is expected.\nAtrophy may be present.  However, for marked muscular atrophy see the criteria for a severe evaluation under\n38 CFR 4.124a, DC 8520\n.\nSevere\nIn general, expect motor and/or reflex impairment (for example, atrophy, weakness, or diminished or hyperactive reflexes) at a grade reflecting a very high level of limitation or disability.\nTrophic changes may be seen in severe longstanding neuropathy cases.\nFor the sciatic nerve (\n38 CFR 4.124a, DC 8520\n) marked muscular atrophy is expected.\nEven though severe incomplete paralysis cases should show findings substantially less than representative findings for complete impairment of the nerve, the disability picture for severe incomplete paralysis may contain signs/symptoms resembling some of those expected in cases of complete paralysis of the nerve.\nNeuritis characterized by loss of reflexes, muscle atrophy, sensory disturbances, and constant pain should be rated as high as severe incomplete paralysis of the nerve (\n38 CFR 4.123\n).\nNotes\n:\nAlways consider the specific criteria in the\n38 CFR 4.124a\nDC at issue, as well as the general guidance on neuritis and neuralgia under\n38 CFR 4.123\nand\n38 CFR 4.124\n.\nThis guidance also applies to radiculopathy, which is evaluated under a peripheral nerve code.\nSeparate evaluations may not be assigned when evaluating an upper extremity peripheral nerve disability. See note under\n38 CFR 4.124a, DC 8719\n.\nReference\n:  For more information on evaluating peripheral nerves, see the\nPeripheral Nerve Evaluation Matrix\n.\nV.iii.12.A.2.d\n.\nConsidering the Complete Findings When Evaluating Incomplete Paralysis\nEvaluation Builder entries must be based upon the\ncomplete findings\nof the DBQ and/or evidentiary record, including\nthe nerve(s) involved\nwhether the impairment involves\nreduced or elevated sensation to various tests, or abnormal sensations\nreduced or hyperactive reflexes\nmuscle weakness\nmuscle atrophy, and/or\ntrophic changes\nthe amount of area in the nerve distribution affected by symptoms\nthe frequency of symptoms,\nand\nthe grade of any impairments that are identified.\nDo not\nbase the entries\nsolely\nupon the examiner’s assessment of the level of incomplete paralysis.\nThe examiner’s clinical assessment of the extent of incomplete paralysis, as indicated on the DBQ, may be inconsistent with or appear to contradict the objective findings that are documented in other sections of the DBQ or other evidence of record.\nImportant\n:  The rating activity, not the examining medical professional, determines whether the overall evidentiary record shows the severity of the condition meets the criteria for a classification of mild, moderate, moderately severe, or severe.\nExample 1\n:  An examiner assesses the peripheral nerve disability as “mild incomplete paralysis.”  However, the DBQ shows muscle weakness, atrophy, and diminished reflexes, which are clearly demonstrative of more than mild incomplete paralysis.  In this case, the complete evidentiary record shows the condition is more than mild under guidance contained in\n38 CFR 4.124\nand therefore warrants a higher evaluation.\nExample 2\n:  An examiner renders an assessment of “severe incomplete paralysis” when the objective test results are wholly sensory.  Therefore, the condition warrants an evaluation no higher than moderate incomplete paralysis under\n38 CFR 4.124a\n.\nReferences\n:  For more information on\ntests for peripheral nerve conditions, see\nM21-1, Part V, Subpart iii, 12.A.2.h\n, and\ninterpretation of examination reports, see\n38 CFR 4.2\n.\nV.iii.12.A.2.e\n.\nNerve Branches of the Lower Extremities for Which Separate Evaluations May Be Assigned\nThe table below lists the five nerve branches of the lower extremities for which separate evaluations may be assigned.  See\nM21-1, Part V, Subpart iii, 12.A.2.f\nfor rating guidance on assigning separate evaluations for nerve conditions of the lower extremities.\nTo assist in evaluating these nerves, the table below also includes any associated nerves in each branch, corresponding DCs under\n38 CFR 4.124a\n, and the general functions covered by each nerve branch.\nLower Extremity Nerve Branches\nFunction\nSciatic\nsciatic nerve (DCs 8520, 8620, and 8720)\nexternal popliteal nerve (common peroneal) (DCs 8521, 8621, and 8721)\nmusculocutaneous nerve (superficial peroneal) (DCs 8522, 8622, and 8722)\nanterior tibial nerve (deep peroneal) (DCs 8523, 8623, and 8723)\ninternal popliteal nerve (tibial) (DCs 8524, 8624, and 8724), and\nposterior tibial nerve (DCs 8525, 8625, and 8725).\nFoot and leg sensory and motor function of the\nbuttock\nleg\nknee\nmuscles below knee\nlower leg\nfibula\nfoot, muscles of foot, sole of foot, plantar flexion, and\ntoes.\nFemoral\nanterior crural nerve (femoral) (DCs 8526, 8626, and 8726), and\ninternal saphenous nerve (DCs 8527, 8627, and 8727).\nThigh and leg sensory and motor function of the\nquadriceps muscle, front of thigh\nmedial calf, and\nmedial malleolus.\nObturator\n(DCs 8528, 8628, and 8728)\nMotor and sensory function of the\nhip and muscles of the hip, and\nmedial thigh.\nExternal cutaneous nerve of thigh\n(DCs 8529, 8629, and 8729)\nSensory function of the lateral thigh.\nIlio-inguinal nerve\n(DCs 8530, 8630, and 8730)\nMotor and sensory function of the\nlower abdominal wall\nthigh\nscrotum, and\nlabia majora.\nV.iii.12.A.2.f\n.\nAssigning Separate Evaluations for Lower Extremity Peripheral Nerves\nUnlike the upper extremities, separate evaluations of the lower extremities may be assigned for symptoms that are separate and distinct, do not overlap, and are attributed to different lower extremity nerves.  This means that separate evaluations\nare\nwarranted when symptoms arise from any of the five nerve branches listed in the table in\nM21-1, Part V, Subpart iii, 12.A.2.e\n.\nIf symptoms arise from within the same nerve branch of any of the five individual nerve branches in the lower extremity, assigning separate evaluations for those symptoms\nare not\nwarranted as this would constitute pyramiding.\nExample 1\n:\nSeparate Evaluations Warranted\nA Veteran has severe incomplete paralysis of the\ncommon peroneal nerve\nand mild incomplete paralysis of the\nfemoral nerve\n.  Assign separate evaluations of 30 percent under\n38 CFR 4.124a, DC 8521\nand 10 percent under\n38 CFR 4.124a, DC 8526\n.\nAnalysis\n:  The common peroneal nerve is part of the sciatic branch and the femoral nerve is part of the femoral branch.  The functions for these branches are separate and distinct and therefore warrant separate evaluations.\nE\nxample 2\n:\nSeparate Evaluations Not Warranted\nA Veteran has severe incomplete paralysis of the\ncommon peroneal nerve\nunder\n38 CFR 4.124a, DC 8521\nand moderate incomplete paralysis of the\ntibial nerve\nunder\n38 CFR 4.124a, DC 8524\n.  In this case, a single 30-percent evaluation is assigned under\n38 CFR 4.124a, DC 8521\n.\nAnalysis\n:  Both of these nerves are part of the same sciatic branch, and therefore the functions associated with these nerves are not separate and distinct.  The 30-percent evaluation shall be assigned under\n38 CFR 4.124a, DC 8521\nsince it represents the predominant disability.\nReferences\n:  For more information on\nseparate evaluations and pyramiding, see\nM21-1, Part V, Subpart ii, 3.D.2.b\n, and\nnerve branches of the lower extremities, see\nM21-1, Part V, Subpart iii, 12.A.2.e\n.\nV.iii.12.A.2.g\n.\nDetermining Individual Nerves Affected in the Upper and Lower Extremities When Evaluating Disabilities\nWhen evaluating peripheral nerve disabilities of the upper and lower extremities, the rating activity must conduct a thorough review of the medical evidence of record to determine the individual nerve(s) affected.\nDepartment of Veterans Affairs (VA) examiners are required, to the extent possible, to select the individual nerves affected when completing DBQs.  However, the examiner may not necessarily conduct a review of all previous clinical records or perform comprehensive tests to pinpoint the exact nerve and/or symptoms attributable to that nerve.\nImportant\n:\nIt is the responsibility of the rating activity, in accordance with\n38 CFR 4.2\n, to interpret the DBQ along with the whole recorded history, and accurately identify and assess the current level of peripheral nerve disability.  This includes identifying the appropriate nerve from a review of the evidence so that the appropriate evaluation can be assigned.\nInclude the following language in all peripheral nerves examination requests:\nExaminer:  Please identify the specific nerve(s) affected.  If you are unable to identify the specific nerve(s), please provide a rationale in the Remarks section.  Thank you\n.\nFollow the guidance in the table below when reviewing medical evidence pertaining to peripheral nerve disabilities of the upper and lower extremities.\nIf the DBQ or equivalent\nindicates\n…\nAnd …\nThen\nevaluate\n…\nthe specific nerve(s) affected\nthere is no conflicting information\nthe specific nerve under the appropriate DC.\nthere is conflicting information on what nerve is affected, but the nerves identified are within the same nerve branch\nthe nerve that is most beneficial to the Veteran as long as the DC supports the symptoms.\nthe identified nerves are in different nerve branches; however, the symptoms identified in the medical evidence are not clearly associated with an individual nerve\nall symptoms shown in the medical evidence for the individual nerve(s) in the associated nerve branches.\nthe examiner is unable to specify the affected nerve(s)\nthere is no other evidence adequately documenting the affected nerve\nupper extremity symptoms using\n38 CFR 4.124a, DC 8514\n(the radial nerve), or\nlower extremity symptoms using\n38 CFR 4.124a, DC 8521\n(the common peroneal nerve).\nException\n:  Where the disability at issue is lower extremity radiculopathy associated with service-connected (SC) thoracolumbar disability, follow the guidance in\nM21-1, Part V, Subpart iii, 1.B.3.d\nand evaluate using\n38 CFR 4.124a, DC 8520\n(the sciatic nerve).\nNote\n:  The nerve branches and general functions of the nerve branches of the lower extremities are described in the table found in\nM21-1, Part V, Subpart iii, 12.A.2.e\n.\nV.iii.12.A.2.h\n.\nEMG and Other Tests for Peripheral Nerve Conditions\nElectromyography (EMG) results are required for evaluations of peripheral nerve disabilities unless there is a previous EMG test of record\nor\nthe record contains sufficient clinical evidence to determine the extent of paralysis in the peripheral nerve.\nAs noted in the\nPeripheral Nerves Conditions (Not Including Diabetic Sensory - Motor Peripheral Neuropathy) Disability Benefits Questionnaire\n, EMG studies are usually rarely required to diagnose specific peripheral nerve conditions in the appropriate clinical setting and, if EMG studies are in the medical record and reflect the Veteran's current condition, repeat studies are not indicated.\nImportant\n:  Ultimately, it is the role of the rating activity to determine if the examination was sufficient to confirm the question and extent of peripheral nerve involvement.\nNote\n:  Other clinical findings that may be sufficient to document a peripheral nerve disability include\nsensation to light touch testing\ndeep tendon reflex testing\ncertain signs for the median nerve\ntrophic changes\ngait testing\nmuscle strength testing, and\nthe presence of muscle atrophy.\nV.iii.12.A.2.i\n.\nApplying the Amputation Rule to Peripheral Nerve Disabilities\nIn determining whether the amputation rule under\n38 CFR 4.68\napplies to peripheral nerve evaluations, decision makers must consider the etiology of the peripheral nerve disability.\nIf the peripheral nerve disability is associated with a musculoskeletal injury or amputation, follow the guidance in\nM21-1, Part V, Subpart iii, 1.E.2.j\nregarding the application of the amputation rule.\nWhen peripheral nerve disabilities are not associated with a musculoskeletal injury, such as diabetic neuropathy, the amputation rule does not apply.\nReference\n:  For more information on evaluating peripheral nerve injuries associated with a muscle injury, see\n38 CFR 4.55\n.\nV.iii.12.A.2.j\n.\nEvaluating Restless Legs Syndrome\nRestless legs syndrome is a neurological disorder characterized by throbbing, pulling, creeping, or other unpleasant sensations in the legs and an uncontrollable, and sometimes overwhelming, urge to move them.  Symptoms occur primarily at night when a person is relaxing or at rest and can increase in severity during the night.\nRestless legs syndrome should be rated under the appropriate peripheral neuropathy code(s) that most closely approximates the area of the extremity or extremities affected by the distribution of the symptoms.\n3\n.\nMigraine Headaches\nIntroduction\nThis topic contains information on migraine headaches, including\nevaluation criteria for migraine headaches\nDC 8100 terminology:\nprostrating\nand\ncompletely prostrating\nrole of medical evidence in establishing the fact of prostration\nlay evidence of prostration from migraine headaches\nDC 8100 terminology:\nsevere economic inadaptability\n, and\nless frequent\nand\nvery frequent\nfrequency determinations: types of proof,\nand\nheadache journals\n.\nChange Date\nSeptember 14, 2023\nV.iii.12.A.3.a\n.\nEvaluation Criteria for Migraine Headaches\nMigraine headaches are evaluated under the criteria of\n38 CFR 4.124a, DC 8100\n.  Evaluations depend primarily on the frequency of attacks and the degree to which symptoms are prostrating.  The extent to which the headaches cause work impairment is also a factor and is considered for the 50-percent evaluation.\nImportant\n:  The Court of Appeals for Veterans Claims, in\nHolmes v. Wilkie\n, 33 Vet.App. 67 (2020), held that the criteria of\n38 CFR 4.124a, DC 8100\n, contemplate more than merely headache symptoms, and that the DC requires VA to\nconsider\nall\nsymptoms experienced as a result of migraine attacks, and\nevaluate those symptoms based on the overall frequency, severity, and economic impact of the migraine attacks.\nExample\n:  A Veteran suffers SC migraine headaches that occur twice weekly and are prostrating in nature.  Symptoms manifested during the migraine headache attacks include frontal headaches, photophobia, nausea, and dizziness.  In evaluating the disability under\n38 CFR 4.124a, DC 8100\n, VA must consider all symptoms associated with the migraine headache attacks, and not just the headaches themselves.\nV.iii.12.A.3.b\n.\nDC 8100 Terminology:  Prostrating and Completely Prostrating\nProstrating\n, as used in\n38 CFR 4.124a, DC 8100\n, means “causing extreme exhaustion, powerlessness, debilitation or incapacitation with substantial inability to engage in ordinary activities.”\nCompletely prostrating\n, as used in\n38 CFR 4.124a, DC 8100\n, means extreme exhaustion or powerlessness with\nessentially total\ninability to engage in ordinary activities.\nV.iii.12.A.3.c\n.\nThe Role of Medical Evidence in Establishing the Fact of Prostration\nAlthough prostration is substantially defined by how the disabled individual subjectively feels and functions when having migraine headache symptoms, medical evidence is required to establish that the reported symptoms are due to the SC migraine headaches.\nThe following is an example of a medical statement that would ordinarily establish the fact of prostration if the medical report and the history provided by the claimant are both credible.\nThe patient reports symptoms of severe head pain, blurred vision, nausea and vomiting, and being unable to tolerate light or noise, worsened by most activities including reading, writing, and engaging in conversations or physical activities.  When experiencing these symptoms, the patient only sleeps or rests.  The symptoms reported by the patient are consistent with the diagnosis of migraine headaches and the reported limitations are consistent with those seen in patients suffering from migraine headaches of similar clinical severity.\nNote\n:  Medical reports may not use the word “prostration.”  However, this is an adjudicative determination based on the extent to which the facts meet the definition of the term.\nV.iii.12.A.3.d\n.\nLay Evidence of Prostration from Migraine Headaches\nA claimant’s own testimony regarding symptoms\nand\nlimitations when having those symptoms can establish prostration as long as the testimony is credible and symptoms are otherwise competently attributed to migraine headaches through medical evidence.\nExample\n:  A claimant provides testimony that she 1) experiences severe headaches and vomiting when exposed to light; 2) does not engage in any activities when this occurs; and 3) must rest or sleep during these episodes.  If there is medical evidence that the claimant’s description of symptoms is in fact symptoms of migraine headaches, a determination that the headaches cause prostration can be made.\nReference\n:  For more information on competency of lay testimony, see\nM21-1, Part V, Subpart ii, 1.B\n, and\nEspiritu v. Derwinski\n, 2 Vet.App. 492 (1992).\nV.iii.12.A.3.e\n.\nDC 8100 Terminology: Severe Economic Inadaptability\nSevere economic inadaptability\ndenotes a degree of substantial work impairment.  It\ndoes not\nmean the individual is incapable of any substantially gainful employment.  Evidence of work impairment includes, but is not necessarily limited to, the use of sick leave or unpaid absence.\nNote\n:  In cases where migraine headaches meet the criterion of severe economic inadaptability and, additionally, the evidence shows that the claimant is incapable of substantially gainful employment due to the headaches, referral for consideration of an extraschedular award of a total evaluation based on individual unemployability is appropriate.\nReference\n:  For more information on severe economic inadaptability, see\nPierce v. Principi\n, 18 Vet.App 440 (2004).\nV.iii.12.A.3.f\n.\nDC 8100 Terminology: Less Frequent and Very Frequent\n38 CFR 4.124a, DC 8100\ndoes not define the terms\nless frequent\nfor the 0- percent criterion or\nvery frequent\nfor the 50-percent criterion.  However, the overall rating criteria structure for migraine headaches provides a basis for guidance.\nAs noted in\n38 CFR 4.124a, DC 8100\n, the 10-percent evaluation specifies average frequency (“averaging one in 2 months over the last several months”), which is half of what is required for a 30-percent evaluation (“on average once a month over the last several months”).\nFor definitions of the terms\nless frequent\nand\nvery frequent\n, refer to the table below.\nTerm\nEvaluation Level\nDefinition\nless frequent\n0 percent\nCharacteristic prostrating attacks, on average, are more than two months apart over the last several months.\nvery frequent\n50 percent\nCharacteristic prostrating attacks, on average, are less than one month apart over the last several months.\nV.iii.12.A.3.g\n.\nFrequency Determinations:  Types of Proof\nFrequency of migraine headache attacks or episodes is a factual determination.  Analyze all evidence in the record bearing on the question.\nProbative evidence may include\nmedical progress notes\ncompetent and credible lay evidence on how often the claimant experiences symptoms (as long as those symptoms have been competently identified as symptoms of migraine headaches)\ncontemporaneous notes (a headache journal)\nprescription refills, and\nwitness statements.\nNote\n:  The absence of treatment reports is not necessarily probative on the question of headache frequency as a claimant may not seek treatment for headaches during every episode.\nReference\n:  For more information on evaluating evidence, including competency and credibility, see\nM21-1, Part V, Subpart ii, 1\n.\nV.iii.12.A.3.h\n.\nHeadache Journals\nHeadache journals, which routinely and relatively contemporaneously record headache episodes, may be accepted as credible lay testimony regarding\nheadache frequency\nprostration, and\noccupational impairment (for example, sick leave due to headaches).\nNote\n:  Headaches recorded on non-work days may be used to prove frequency and prostration.  However, they will not generally be relevant to work availability, and performance or limitations, which are considerations in determining severe economic inadaptability.\n﻿﻿<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><div class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180518\" articlename=\"M21-1, Part V, Subpart iii, Chapter 11 - Endocrine Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180518/M21-1-Part-V-Subpart-iii-Chapter-11-Endocrine-Conditions\">﻿﻿&lt;-- Previous Section</a>  <a articleid=\"554400000180832\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section B - Traumatic Brain Injury (TBI)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180832/M21-1-Part-V-Subpart-iii-Chapter-12-Section-B-Traumatic-Brain-Injury-TBI\">Next Section --&gt;</a></span></span></div><h2 class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\">Overview</span></a></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px; vertical-align: top\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 16px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">In This Section</span></span></h3></td><td style=\"height: 16px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 16px; width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> This section contains the following topics:</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 499px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\"><thead><tr><th scope=\"col\" style=\"width: 86px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Topic</strong></span></span></div></th><th scope=\"col\" style=\"width: 423px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Topic Name</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">1 </span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\">General Information on Neurological and Convulsive Disorders</span></a></span></div></td></tr><tr><td style=\"width: 86px; vertical-align: middle; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">2</span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\">Peripheral Nerves</span></a></span></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">3</span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3\" target=\"_self\"><span style=\"font-size: 14px\">Migraine Headaches</span></a></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"><br/><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div><h2 class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\">1<a id=\"1\" name=\"1\">.</a>  General Information on Neurological and Convulsive Disorders</span></span></h2><div class=\"ng-scope\"><br/><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px; vertical-align: top\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 112px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Introduction</span></span></h3></td><td style=\"height: 112px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 112px; width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This topic contains general information about neurological and convulsive disorders, including</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\">considerations in service connection (SC) for neurological disorders</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1b\" target=\"_self\">identifying epilepsy</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\">evaluating progressive spinal muscular atrophy</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1d\" target=\"_self\">other organic diseases of the nervous system under 38 CFR 3.309(a)</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1e\" target=\"_self\">SC of vertigo</a>, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1f\" target=\"_self\">requesting examinations for manifestations of central nervous system diseases</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Change Date</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">February 26, 2025</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.1.a<a id=\"1a\" name=\"1a\">.</a>  Considerations in SC for Neurological Disorders</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">See the table below for etiological considerations and manifestations involving specific neurological disorders.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 501px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an When-Then table.  Column 1 provides the criteria and column 2 provides the actions to take for etiological considerations and manifestations involving specific neurological disorder\" width=\"501\"><thead><tr><th scope=\"col\" style=\"width: 51.24%; padding: 1px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>When ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 48.76%; padding: 1px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 51%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">considering questions of incurrence or aggravation in service</span></span></div></td><td style=\"width: 48%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">bear in mind the etiology and clinical course of each separate disease.</span></span></div></td></tr><tr><td style=\"width: 51%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">considering conditions of infectious origin</span></span></div></td><td style=\"width: 48%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">consider both the circumstances of infection and the incubation period.</span></span></div></td></tr><tr><td style=\"width: 51%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">determining aggravation for conditions such as multiple sclerosis (MS), progressive muscular atrophy, and myasthenia gravis</span></span></div></td><td style=\"width: 48%; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">be aware that increased symptomatology over a period of a few months may reflect natural progression of the disease.  Base determinations on the developed medical evidence of record.</span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.1.b<a id=\"1b\" name=\"1b\">.</a>  Identifying Epilepsy</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Seizures must be witnessed <em>or</em> verified by a physician to warrant service connection (SC) for epilepsy.  Verification may be by an electroencephalogram (EEG), which measures electrical activity in the brain.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">A physician does not have to witness an actual seizure before a diagnosis of epilepsy can be accepted for evaluation purposes.  Verification by a physician based upon factors other than observing an actual seizure is sufficient.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">identifying epilepsy, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.4_1121&amp;rgn=div8\" target=\"_blank\">38 CFR 4.121</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">psychomotor epilepsy, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.4_1122&amp;rgn=div8\" target=\"_blank\">38 CFR 4.122</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.12.A.1.c<a id=\"1c\" name=\"1c\">.</a>  Evaluating Progressive Spinal Muscular Atrophy</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Progressive muscular atrophy, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, diagnostic code (DC) 8023</a>, refers to progressive spinal muscular atrophy, which is a disease of the spinal cord.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Progressive muscular atrophy is subject to presumptive SC under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(a)</a> because it is an organic disease of the nervous system.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px; vertical-align: top\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.1.d<a id=\"1d\" name=\"1d\">.</a>  Other Organic Diseases of the Nervous System Under 38 CFR 3.309(a)</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">For purposes of establishing presumptive SC for a chronic disease under <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=7bb77fadaa9b6f28b29ee834697f0824&amp;mc=true&amp;r=SECTION&amp;n=se38.1.3_1307\" target=\"_blank\">38 CFR 3.307</a>, the term <strong><em>other organic diseases of the nervous system</em></strong> in <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=7bb77fadaa9b6f28b29ee834697f0824&amp;mc=true&amp;r=SECTION&amp;n=se38.1.3_1309\" target=\"_blank\">38 CFR 3.309(a)</a> includes any commonly recognized neurological disease (such as may be found in a valid contemporary medical treatise), which is not otherwise specifically enumerated under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(a)</a>.  This includes, <em>but is not limited to</em>, the following conditions:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">carpal tunnel syndrome</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">migraine headaches</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">sensorineural hearing loss</span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">tinnitus</span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">glaucoma</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">progressive spinal muscular atrophy</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">diseases of the cranial nervous system</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">cranial nerve conditions, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">peripheral nerve conditions, such as peripheral neuropathy.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Important</em></strong>:  If there is uncertainty as to whether or not a claimed disability may be considered as an organic disease of the nervous system for purposes of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(a)</a>, send the case to Compensation Service for guidance.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> <br/><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">presumptive SC, see <a articleid=\"554400000180482\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section B - Presumptive Service Connection (SC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180482/M21-1-Part-V-Subpart-ii-Chapter-2-Section-B-Presumptive-Service-Connection-SC\">M21-1, Part V, Subpart ii, 2.B</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">referring a claim for an advisory opinion, see <a articleid=\"554400000177996\" articlename=\"M21-1, Part X, Subpart v, Chapter 1, Section A  - Compensation Service and Pension and Fiduciary (P&amp;F) Service Guidance\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177996/M21-1-Part-X-Subpart-v-Chapter-1-Section-A-Compensation-Service-and-Pension-and-Fiduciary-PF-Service-Guidance\">M21-1, Part X, Subpart v, 1.A.2</a>, and</span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">establishing SC for hearing loss and tinnitus, see <a articleid=\"554400000014464\" articlename=\"M21-1, Part V, Subpart iii, Chapter 2, Section B - Conditions of the Auditory System\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014464/M21-1-Part-V-Subpart-iii-Chapter-2-Section-B-Conditions-of-the-Auditory-System\">M21-1, Part V, Subpart iii, 2.B</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.12.A.1.e<a id=\"1e\" name=\"1e\">.</a>   SC of Vertigo</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Carefully consider the evidence of record when considering SC for vertigo.  Vertigo is generally considered a symptom of another disability such as traumatic brain injury (TBI), Meniere's disease, vestibular neuritis/labyrinthitis, MS, stroke or tumor.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When the disability manifested by vertigo is adequately identified, SC should be established for that diagnosis rather than for \"vertigo.\"  However, SC can be established for \"vertigo\" in the absence of a known or established underlying etiology if there is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">an event in service (such as a nonspecific diagnosis of vertigo in service)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">vertigo present post service</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a nexus establishing the vertigo post service is connected to the event in service, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the condition is <em>not</em> associated with any other disease or injury.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">evaluating vertigo as a symptom of TBI and the prohibition against evaluating vertigo separately from TBI, see <a articleid=\"554400000180832\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section B - Traumatic Brain Injury (TBI)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180832/M21-1-Part-V-Subpart-iii-Chapter-12-Section-B-Traumatic-Brain-Injury-TBI\">M21-1, Part V, Subpart iii, 12.B.1.i</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">principles related to SC, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=3cd0aebbeedd74c20521818b2c0b4cf5&amp;mc=true&amp;r=SECTION&amp;n=se38.1.3_1303\" target=\"_blank\">38 CFR 3.303</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000180481\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section A - Direct Service Connection (SC) and Service Incurrence of an Injury\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180481/M21-1-Part-V-Subpart-ii-Chapter-2-Section-A-Direct-Service-Connection-SC-and-Service-Incurrence-of-an-Injury\">M21-1, Part V, Subpart ii, 2</a>.</span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.12.A.1.f<a id=\"1f\" name=\"1f\">.</a>  Requesting Examinations for Manifestations of Central Nervous System Diseases  </span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">All manifestations or residuals of a central nervous system disease under <a href=\"https://www.ecfr.gov/current/title-38/section-4.124a\" target=\"_blank\">38 CFR 4.124a, DCs 8000-8025</a>, must be examined using <i>only</i> the applicable disability benefits questionnaire (DBQ) for the primary or underlying central nervous system disease.  Do <i>not</i> request a different DBQ specifically for any manifestations or residuals, as these are accounted for in the DBQ for the primary or underlying disease.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Note</i></b>:  This applies in all cases where an examination is needed for such manifestations or residuals, even if the primary or underlying central nervous system disease itself is not at issue in the associated claim.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Exception</i></b>:  When the disabling manifestation requires a specialist examination, as outlined in <a articleid=\"554400000180498\" articlename=\"M21-1, Part IV, Subpart i, Chapter 2, Section A - Examination Requests Overview\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180498/M21-1-Part-IV-Subpart-i-Chapter-2-Section-A-Examination-Requests-Overview\">M21-1, Part IV, Subpart i, 2.A.1.g</a>, request the specific DBQ for the condition requiring a specialist examination.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Example</i></b>:  Do <b><i>not</i></b> request a <i>Peripheral Nerves Conditions Disability Benefits Questionnaire</i> for evaluation of extremity tremor and weakness due to Parkinson’s disease.  Request <b><i>only</i></b> the <i>Parkinson’s Disease Disability Benefits Questionnaire</i>, which includes an assessment for impairment of the extremities.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">examination requests, see <a articleid=\"554400000180498\" articlename=\"M21-1, Part IV, Subpart i, Chapter 2, Section A - Examination Requests Overview\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180498/M21-1-Part-IV-Subpart-i-Chapter-2-Section-A-Examination-Requests-Overview\">M21-1, Part IV, Subpart i, 2.A</a></span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">progressive neurological disorders, see <a articleid=\"554400000180833\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section C - Progressive Neurological Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180833/M21-1-Part-V-Subpart-iii-Chapter-12-Section-C-Progressive-Neurological-Disorders\">M21-1, Part V, Subpart iii, 12.C</a>, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">DBQs, see the <a href=\"http://vbacoweba5.vba.va.gov/bl/21/DBQ/default.asp\" target=\"_blank\"><i>DBQ Switchboard</i></a>. </span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"><br/><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div><h2 class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\">2<a id=\"2\" name=\"2\">.</a>  Peripheral Nerves</span></span></h2><div class=\"ng-scope\" style=\"margin-left: 85pt\"><br/><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">    </span></span></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Introduction</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This topic contains information on evaluating peripheral nerves, including</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\"><span style=\"font-size: 14px\">regulations for evaluating peripheral nerves</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\"><span style=\"font-size: 14px\">38 CFR 4.124a guidance on evaluating completely sensory peripheral nerve impairment</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\">assigning level of incomplete paralysis</span>, neuritis, or neuralgia</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\"><span style=\"font-size: 14px\">considering the complete findings when evaluating incomplete paralysis</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\"><span style=\"font-size: 14px\">nerve branches of the lower extremities for which separate evaluations may be assigned</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2f\" target=\"_self\"><span style=\"font-size: 14px\">assigning separate evaluations for lower extremity peripheral nerves</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#2g\" target=\"_self\">determining individual nerves affected in the upper and lower extremities when evaluating disabilities</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#2h\" target=\"_self\">electromyography (EMG) and other tests for peripheral nerve conditions</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2i\" target=\"_self\">applying the amputation rule to peripheral nerve disabilities</a></span></span><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2j\" target=\"_self\">evaluating restless legs syndrome</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Change Date</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">April 16, 2020</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.a<a id=\"2a\" name=\"2a\">.</a> Regulations for Evaluating Peripheral Nerves</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DCs 8510-8730</a>, provides evaluation levels for complete paralysis, incomplete paralysis, neuritis, or neuralgia of peripheral nerves.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">At the beginning of the DCs for the peripheral nerves, the regulation also states that “incomplete paralysis” anticipates substantially less impaired function than described for complete paralysis of the nerve.  When impairment is wholly sensory, the evaluation should be that specified for the <em>mild</em>, or at most, the <em>moderate</em> degree of incomplete paralysis for the nerve.</span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The regulations listed below also provide guidance on evaluating peripheral nerves.  </span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_1120&amp;rgn=div8\" target=\"_blank\">38 CFR 4.120</a> provides that when rating peripheral nerve injuries and residuals consider the relative impairment of motor function, trophic changes, and/or sensory disturbances.  Attention should be given to the site and character of the injury.</span></span></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1123\" target=\"_blank\">38 CFR 4.123</a> provides several principles relating to peripheral nerves:</span></span></span></span></span></span></span></span></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Neuritis, characterized by loss of reflexes, muscle atrophy, sensory disturbances, and constant pain, is to be rated on the scale provided for injury of the nerve involved under the DCs and evaluations provided in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a>.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The maximum evaluation for neuritis is the evaluation provided for <em>severe</em> incomplete paralysis of the affected nerve. </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The maximum evaluation that may be assigned for neuritis <em><strong>not </strong></em>characterized by the organic changes referred to in the regulation</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">is generally the evaluation level specified for <em>moderate</em> incomplete paralysis of the nerve, <strong><em>but</em></strong></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">is the evaluation level specified for <em>moderately severe</em> impairment when the affected nerve is the sciatic nerve. </span></span></div></li></ul></li></ul><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1124\" target=\"_blank\">38 CFR 4.124</a> provides that the maximum evaluation for neuralgia, characterized usually by a dull and intermittent pain in the distribution of a nerve, should be the evaluation provided for <em>moderate</em> incomplete paralysis of the nerve under the </span><span style=\"font-size: 14px\">applicable DC.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.b<a id=\"2b\" name=\"2b\">.</a>      38 CFR 4.124a Guidance on Evaluating Completely Sensory Peripheral Nerve Impairment</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">In cases where a peripheral nerve disability is only manifested by sensory impairment, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a> directs decision makers to assign the evaluation corresponding with the mild <strong><em>or at most</em></strong> the moderate degree of impairment. </span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">To make a choice between mild and moderate, consider the evidence of record and the following guidelines:</span></span></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The mild level of evaluation would be more reasonably assigned when sensory symptoms are</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">recurrent but not continuous</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">assigned a lower medical grade reflecting less impairment, and/or</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">affecting a smaller area in the nerve distribution. </span></span></div></li></ul></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Reserve the moderate level of evaluation for the most significant and disabling cases of sensory-only involvement.  These are cases where the sensory symptoms are</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">continuous</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">assigned a higher medical grade reflecting greater impairment, </span></span><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">and/or </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">affecting a larger area in the nerve distribution. </span></span></div></li></ul></li></ul><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Important</em></strong>:  This provision <strong><em>does not</em></strong> mean that if there is <em>any</em> impairment that is non-sensory (or involves a non-sensory component) such as a reflex abnormality, weakness, or muscle atrophy, the disability must be evaluated as greater than moderate.  Significant and widespread sensory impairment may potentially indicate the same or even more disability than a case involving a minimally reduced or increased reflex or minimally reduced strength.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating wholly sensory manifestations of peripheral nerves, see <a articleid=\"554400000068108\" articlename=\"Miller v. Shulkin, Mar 6, 2017, 28 Vet.App. 376 (2017)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000068108/Miller-v-Shulkin-Mar-6-2017-28-VetApp-376-2017\"><em>Miller v. Shulkin</em></a>, 28 Vet.App. 376 (2017)</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">considering the complete findings when evaluating incomplete paralysis, see <a href=\"#2d\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.d</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the importance of fully descriptive examinations and limitations from the disabling condition, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_11&amp;rgn=div8\" target=\"_blank\">38 CFR 4.1</a>, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the importance of coordinating the evaluation with impairment of function based on sufficiently characteristic findings, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_121&amp;rgn=div8\" target=\"_blank\">38 CFR 4.21</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 114px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.c<a id=\"2c\" name=\"2c\">.</a>  Assigning Level of Incomplete Paralysis, Neuritis, or Neuralgia</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The table below provides general guidelines for each level of incomplete paralysis of the upper and lower peripheral nerves.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 472px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a degree of incomplete paralysis-description table.  Column 1 contains the degree of incomplete paralysis and column 2 contains the description.\" width=\"472\"><thead><tr><th scope=\"col\" style=\"width: 238px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Degree of Incomplete Paralysis</strong></span></span></div></th><th scope=\"col\" style=\"width: 384px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Description</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 238px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Mild</span></span></div></td><td style=\"width: 384px; vertical-align: top; text-align: left; padding: 1px;\"><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">As this is the lowest level of evaluation for each nerve, this is the default assigned based on the symptoms, however slight, as long as they were sufficient to support a diagnosis of the peripheral nerve impairment for SC purposes.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">In general, look for a disability limited to sensory deficits that are lower graded, less persistent, or affecting a small area.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">A very minimal reflex or motor abnormality potentially could also be consistent with mild incomplete paralysis.</span></span></div></li></ul></td></tr><tr><td style=\"width: 238px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Moderate﻿﻿</span></span></div></td><td style=\"width: 384px; vertical-align: top; text-align: left; padding: 1px;\"><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Moderate is the maximum evaluation reserved for the most significant cases of sensory-only impairment (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a>).  </span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Symptoms will likely be described by the claimants and medically graded as significantly disabling.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">In such cases a larger area in the nerve distribution may be affected by sensory symptoms.</span></span></div></li></ul></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Other sign/symptom combinations that may fall into the moderate category include </span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">combinations of significant sensory changes and reflex or motor changes of a lower degree, or</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">motor and/or reflex impairment such as weakness or diminished or hyperactive reflexes (with or without sensory impairment) graded as medically moderate.</span></span></div></li></ul></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Moderate is also the maximum evaluation that can be assigned for </span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">neuritis not characterized by organic changes referred to in <a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1123\" target=\"_blank\">38 CFR 4.123</a>, or</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">neuralgia characterized usually by a dull and intermittent pain in the distribution of a nerve (<a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1124\" target=\"_blank\">38 CFR 4.124</a>).</span></span></div></li></ul></li></ul></td></tr><tr><td style=\"width: 238px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Moderately Severe</span></span></div></td><td style=\"width: 384px; vertical-align: top; text-align: left; padding: 1px;\"><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The moderately severe evaluation level is only applicable for involvement of the sciatic nerve.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This is the maximum rating for sciatic nerve neuritis not characterized by the organic changes specified in <a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1123\" target=\"_blank\">38 CFR 4.123</a>.  </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Motor and/or reflex impairment (for example, weakness or diminished or hyperactive reflexes) at a grade reflecting a high level of limitation or disability is expected.  </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Atrophy may be present.  However, for marked muscular atrophy see the criteria for a severe evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=9f4321aacd8c092edc0248be8bca1242&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8520</a>.</span></span></div></li></ul></td></tr><tr><td style=\"width: 238px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Severe</span></span></div></td><td style=\"width: 384px; vertical-align: top; text-align: left; padding: 1px;\"><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">In general, expect motor and/or reflex impairment (for example, atrophy, weakness, or diminished or hyperactive reflexes) at a grade reflecting a very high level of limitation or disability.  </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Trophic changes may be seen in severe longstanding neuropathy cases.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">For the sciatic nerve (<a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1124a\" target=\"_blank\">38 CFR 4.124a, DC 8520</a>) marked muscular atrophy is expected.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Even though severe incomplete paralysis cases should show findings substantially less than representative findings for complete impairment of the nerve, the disability picture for severe incomplete paralysis may contain signs/symptoms resembling some of those expected in cases of complete paralysis of the nerve.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\">Neuritis characterized by loss of reflexes, muscle atrophy, sensory disturbances, and constant pain should be rated as high as severe incomplete paralysis of the nerve (<a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=c57cdeff39f8794ce53822404bf19c6c&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1123\" target=\"_blank\">38 CFR 4.123</a>).</span></span></span></div></li></ul></td></tr></tbody></table><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Notes</em></strong>:</span></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Always consider the specific criteria in the <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a> DC at issue, as well as the general guidance on neuritis and neuralgia under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1123&amp;rgn=div8\" target=\"_blank\">38 CFR 4.123</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124</a>.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This guidance also applies to radiculopathy, which is evaluated under a peripheral nerve code.</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Separate evaluations may not be assigned when evaluating an upper extremity peripheral nerve disability. See note under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8719</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluating peripheral nerves, see the <a href=\"http://vbaw.vba.va.gov/bl/21/rating/rat00.htm\" target=\"_blank\"><em>Peripheral Nerve Evaluation Matrix</em></a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 151px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.d<a id=\"2d\" name=\"2d\">.</a>  Considering the Complete Findings When Evaluating Incomplete Paralysis</span></span></h3></td><td style=\"height: 151px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 151px; width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluation Builder entries must be based upon the <em>complete findings</em> of the DBQ and/or evidentiary record, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the nerve(s) involved</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">whether the impairment involves</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">reduced or elevated sensation to various tests, or abnormal sensations</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">reduced or hyperactive reflexes</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">muscle weakness</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">muscle atrophy, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">trophic changes</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the amount of area in the nerve distribution affected by symptoms</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the frequency of symptoms, <strong><em>and</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the grade of any impairments that are identified. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Do not</em></strong> base the entries <em>solely</em> upon the examiner’s assessment of the level of incomplete paralysis.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The examiner’s clinical assessment of the extent of incomplete paralysis, as indicated on the DBQ, may be inconsistent with or appear to contradict the objective findings that are documented in other sections of the DBQ or other evidence of record.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  The rating activity, not the examining medical professional, determines whether the overall evidentiary record shows the severity of the condition meets the criteria for a classification of mild, moderate, moderately severe, or severe.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 1</em></strong>:  An examiner assesses the peripheral nerve disability as “mild incomplete paralysis.”  However, the DBQ shows muscle weakness, atrophy, and diminished reflexes, which are clearly demonstrative of more than mild incomplete paralysis.  In this case, the complete evidentiary record shows the condition is more than mild under guidance contained in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124</a> and therefore warrants a higher evaluation.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 2</em></strong>:  An examiner renders an assessment of “severe incomplete paralysis” when the objective test results are wholly sensory.  Therefore, the condition warrants an evaluation no higher than moderate incomplete paralysis under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">tests for peripheral nerve conditions, see <a href=\"#2h\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.h</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">interpretation of examination reports, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_12&amp;rgn=div8\" target=\"_blank\">38 CFR 4.2</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 73px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.e<a id=\"2e\" name=\"2e\">.</a> Nerve Branches of the Lower Extremities for Which Separate Evaluations May Be Assigned</span></span></h3></td><td style=\"height: 73px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 73px; width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The table below lists the five nerve branches of the lower extremities for which separate evaluations may be assigned.  See <a href=\"#2f\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.f</a> for rating guidance on assigning separate evaluations for nerve conditions of the lower extremities.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">To assist in evaluating these nerves, the table below also includes any associated nerves in each branch, corresponding DCs under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=993c22295f9daae770ddf81859d7bcab&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a</a>, and the general functions covered by each nerve branch. </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 503px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a lower extremity nerve branches-function table.  Column 1 contains the lower extremity nerve branch and column 2 contains the function.\" width=\"503\"><thead><tr><th scope=\"col\" style=\"width: 311px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Lower Extremity Nerve Branches </strong></span></span></div></th><th scope=\"col\" style=\"width: 311px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Function</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><em><strong>Sciatic</strong></em></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">sciatic nerve (DCs 8520, 8620, and 8720)</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">external popliteal nerve (common peroneal) (DCs 8521, 8621, and 8721)</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">musculocutaneous nerve (superficial peroneal) (DCs 8522, 8622, and 8722)</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">anterior tibial nerve (deep peroneal) (DCs 8523, 8623, and 8723)</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">internal popliteal nerve (tibial) (DCs 8524, 8624, and 8724), and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">posterior tibial nerve (DCs 8525, 8625, and 8725).</span></span></div></li></ul></td><td style=\"width: 311px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Foot and leg sensory and motor function of the</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">buttock</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">leg</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">knee</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">muscles below knee</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">lower leg</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">fibula</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">foot, muscles of foot, sole of foot, plantar flexion, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">toes.</span></span></div></li></ul></td></tr><tr><td style=\"width: 311px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Femoral</em></strong></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">anterior crural nerve (femoral) (DCs 8526, 8626, and 8726), and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">internal saphenous nerve (DCs 8527, 8627, and 8727).</span></span></div></li></ul></td><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Thigh and leg sensory and motor function of the</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">quadriceps muscle, front of thigh</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">medial calf, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">medial malleolus.</span></span></div></li></ul></td></tr><tr><td style=\"width: 311px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Obturator </em></strong>(DCs 8528, 8628, and 8728)</span></span></div></td><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Motor and sensory function of the</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">hip and muscles of the hip, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">medial thigh.</span></span></div></li></ul></td></tr><tr><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>External cutaneous nerve of thigh </em></strong>(DCs 8529, 8629, and 8729)</span></span></div></td><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Sensory function of the lateral thigh.</span></span></div></td></tr><tr><td style=\"width: 311px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Ilio-inguinal nerve </em></strong>(DCs 8530, 8630, and 8730)</span></span></div></td><td style=\"width: 311px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Motor and sensory function of the</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">lower abdominal wall</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">thigh</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">scrotum, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">labia majora.</span></span></div></li></ul></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.f<a id=\"2f\" name=\"2f\">.</a>  Assigning Separate Evaluations for Lower Extremity Peripheral Nerves</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Unlike the upper extremities, separate evaluations of the lower extremities may be assigned for symptoms that are separate and distinct, do not overlap, and are attributed to different lower extremity nerves.  This means that separate evaluations <strong><em>are</em></strong> warranted when symptoms arise from any of the five nerve branches listed in the table in <a href=\"#2e\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.e</a>.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">If symptoms arise from within the same nerve branch of any of the five individual nerve branches in the lower extremity, assigning separate evaluations for those symptoms <strong><em>are not</em></strong> warranted as this would constitute pyramiding.</span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Example 1</em></strong>:  <strong><em>Separate Evaluations Warranted</em></strong></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">A Veteran has severe incomplete paralysis of the <em>common peroneal nerve </em>and mild incomplete paralysis of the <em>femoral nerve</em>.  Assign separate evaluations of 30 percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8521</a> and 10 percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8526</a>.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Analysis</em></strong>:  The common peroneal nerve is part of the sciatic branch and the femoral nerve is part of the femoral branch.  The functions for these branches are separate and distinct and therefore warrant separate evaluations.</span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong><span style=\"font-size: 14px\"> </span></strong></em></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong><span style=\"font-size: 14px\">E</span></strong></em><span style=\"font-size: 14px\"><strong><em>xample 2</em></strong>:<strong><em>  Separate Evaluations Not Warranted</em></strong></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">A Veteran has severe incomplete paralysis of the <em>common peroneal nerve</em> under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8521</a> and moderate incomplete paralysis of the <em>tibial nerve</em> under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8524</a>.  In this case, a single 30-percent evaluation is assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8521</a>.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Analysis</em></strong>:  Both of these nerves are part of the same sciatic branch, and therefore the functions associated with these nerves are not separate and distinct.  The 30-percent evaluation shall be assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8521</a> since it represents the predominant disability.</span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>  </em></strong></span></span></span></span></span></span></div><div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></span></span></span></span></div></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">separate evaluations and pyramiding, see </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.b</a>, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">nerve branches of the lower extremities, see <a href=\"#2e\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.e</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.g<a id=\"2g\" name=\"2g\">.</a>  Determining Individual Nerves Affected in the Upper and Lower Extremities When Evaluating Disabilities</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">When evaluating peripheral nerve disabilities of the upper and lower extremities, the rating activity must conduct a thorough review of the medical evidence of record to determine the individual nerve(s) affected. </span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Department of Veterans Affairs (VA) examiners are required, to the extent possible, to select the individual nerves affected when completing DBQs.  However, the examiner may not necessarily conduct a review of all previous clinical records or perform comprehensive tests to pinpoint the exact nerve and/or symptoms attributable to that nerve. </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Important</em></strong>:  </span></span></span></span></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">It is the responsibility of the rating activity, in accordance with <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=993c22295f9daae770ddf81859d7bcab&amp;mc=true&amp;node=se38.1.4_12&amp;rgn=div8\" target=\"_blank\">38 CFR 4.2</a>, to interpret the DBQ along with the whole recorded history, and accurately identify and assess the current level of peripheral nerve disability.  This includes identifying the appropriate nerve from a review of the evidence so that the appropriate evaluation can be assigned. </span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Include the following language in all peripheral nerves examination requests: </span></span></div></li></ul><div style=\"margin-left: 80px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><em><span style=\"font-size: 14px\"><em>Examiner:  Please identify the specific nerve(s) affected.  If you are unable to identify the specific nerve(s), please provide a rationale in the Remarks section.  Thank you</em>.</span></em></span></span></div><div style=\"margin-left: 80px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Follow the guidance in the table below when reviewing medical evidence pertaining to peripheral nerve disabilities of the upper and lower extremities.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 489px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a DBQ equivalent indicates-and-then table.  Column 1 contains the first criteria, column 2 contains the second criteria and column 3 contains the guidance when reviewing medical evidence pertaining to peripheral nerve disabilites of the upper and lower extremities.\" width=\"489\"><thead><tr><th scope=\"col\" style=\"width: 216px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>If the DBQ or equivalent <strong>indicates </strong>…</strong></span></span></div></th><th scope=\"col\" style=\"width: 222px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>And …</strong></span></span></div></th><th scope=\"col\" style=\"width: 192px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Then <strong>evaluate </strong>…</strong></span></span></div></th></tr></thead><tbody><tr><td rowspan=\"3\" style=\"width: 216px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the specific nerve(s) affected</span></span></div></td><td style=\"width: 222px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">there is no conflicting information</span></span></div></td><td style=\"width: 192px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the specific nerve under the appropriate DC.</span></span></div></td></tr><tr><td style=\"width: 222px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">there is conflicting information on what nerve is affected, but the nerves identified are within the same nerve branch</span></span></div></td><td style=\"width: 192px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the nerve that is most beneficial to the Veteran as long as the DC supports the symptoms.</span></span></div></td></tr><tr><td style=\"width: 222px; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the identified nerves are in different nerve branches; however, the symptoms identified in the medical evidence are not clearly associated with an individual nerve</span></span></div></td><td style=\"width: 192px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">all symptoms shown in the medical evidence for the individual nerve(s) in the associated nerve branches.</span></span></div></td></tr><tr><td style=\"width: 216px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the examiner is unable to specify the affected nerve(s)</span></span></div></td><td style=\"width: 222px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">there is no other evidence adequately documenting the affected nerve</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">upper extremity symptoms using <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=97036cf0c5662e736e138c4825800912&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8514</a> (the radial nerve), or</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">lower extremity symptoms using <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=97036cf0c5662e736e138c4825800912&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8521</a> (the common peroneal nerve). </span></span></div></li></ul><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Exception</em></strong>:  Where the disability at issue is lower extremity radiculopathy associated with service-connected (SC) thoracolumbar disability, follow the guidance in <a articleid=\"554400000014410\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section B - Musculoskeletal Disabilities of the Extremities and Spine\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014410/M21-1-Part-V-Subpart-iii-Chapter-1-Section-B-Musculoskeletal-Disabilities-of-the-Extremities-and-Spine\">M21-1, Part V, Subpart iii, 1.B.3.d</a> and evaluate using <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=97036cf0c5662e736e138c4825800912&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8520</a> (the sciatic nerve).</span></span></div></td></tr></tbody></table><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Note</em></strong>:  The nerve branches and general functions of the nerve branches of the lower extremities are described in the table found in <a href=\"#2e\" target=\"_self\">M21-1, Part V, Subpart iii, 12.A.2.e</a>.</span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.h<a id=\"2h\" name=\"2h\">.</a>   EMG and Other Tests for Peripheral Nerve Conditions</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Electromyography (EMG) results are required for evaluations of peripheral nerve disabilities unless there is a previous EMG test of record <em>or</em> the record contains sufficient clinical evidence to determine the extent of paralysis in the peripheral nerve.</span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">As noted in the <em>Peripheral Nerves Conditions (Not Including Diabetic Sensory - Motor Peripheral Neuropathy) Disability Benefits Questionnaire</em>, EMG studies are usually rarely required to diagnose specific peripheral nerve conditions in the appropriate clinical setting and, if EMG studies are in the medical record and reflect the Veteran's current condition, repeat studies are not indicated. </span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Important</em></strong>:  Ultimately, it is the role of the rating activity to determine if the examination was sufficient to confirm the question and extent of peripheral nerve involvement.</span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em> </em></strong></span></span></span></span></span></span></span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Note</em></strong>:  Other clinical findings that may be sufficient to document a peripheral nerve disability include</span></span></span></span></span></span></span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">sensation to light touch testing</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">deep tendon reflex testing</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">certain signs for the median nerve</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">trophic changes</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">gait testing</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">muscle strength testing, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">the presence of muscle atrophy. </span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.i<a id=\"2i\" name=\"2i\">.</a>   Applying the Amputation Rule to Peripheral Nerve Disabilities</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In determining whether the amputation rule under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_168&amp;rgn=div8\" target=\"_blank\">38 CFR 4.68</a> applies to peripheral nerve evaluations, decision makers must consider the etiology of the peripheral nerve disability.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If the peripheral nerve disability is associated with a musculoskeletal injury or amputation, follow the guidance in </span></span><a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart iii, 1.E.2.j</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> regarding the application of the amputation rule.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When peripheral nerve disabilities are not associated with a musculoskeletal injury, such as diabetic neuropathy, the amputation rule does not apply.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluating peripheral nerve injuries associated with a muscle injury, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=1b4e99c4e9c6fe666246fbc96c1486b3&amp;mc=true&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.2.j<a id=\"2j\" name=\"2j\">.</a>  Evaluating Restless Legs Syndrome</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Restless legs syndrome is a neurological disorder characterized by throbbing, pulling, creeping, or other unpleasant sensations in the legs and an uncontrollable, and sometimes overwhelming, urge to move them.  Symptoms occur primarily at night when a person is relaxing or at rest and can increase in severity during the night.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Restless legs syndrome should be rated under the appropriate peripheral neuropathy code(s) that most closely approximates the area of the extremity or extremities affected by the distribution of the symptoms.</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"><br/><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div><h2 class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\">3<a id=\"3\" name=\"3\">.</a>  Migraine Headaches</span></span></h2><div class=\"ng-scope\" style=\"margin-left: 85.7pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px; vertical-align: top\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 192px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Introduction</span></span></h3></td><td style=\"height: 192px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 192px; width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This topic contains information on migraine headaches, including</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3a\" target=\"_self\"><span style=\"font-size: 14px\">evaluation criteria for migraine headaches</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3b\" target=\"_self\"><span style=\"font-size: 14px\">DC 8100 terminology: <em>prostrating</em> and <em>completely prostrating</em></span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3c\" target=\"_self\"><span style=\"font-size: 14px\">role of medical evidence in establishing the fact of prostration</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3d\" target=\"_self\"><span style=\"font-size: 14px\">lay evidence of prostration from migraine headaches</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">DC 8100 terminology: </span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3e\" target=\"_self\"><span style=\"font-size: 14px\"><em>severe economic inadaptability</em></span></a><span style=\"font-size: 14px\">, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3f\" target=\"_self\"><span style=\"font-size: 14px\"><em>less frequent</em> and <em>very frequent</em></span></a></span></div></li></ul></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#3g\" target=\"_self\">frequency determinations: types of proof,</a> and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#3h\" target=\"_self\">headache journals</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Change Date</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">September 14, 2023</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.a<a id=\"3a\" name=\"3a\">.</a>  Evaluation Criteria for Migraine Headaches</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Migraine headaches are evaluated under the criteria of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>.  Evaluations depend primarily on the frequency of attacks and the degree to which symptoms are prostrating.  The extent to which the headaches cause work impairment is also a factor and is considered for the 50-percent evaluation.</span></span></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:  The Court of Appeals for Veterans Claims, in <a articleid=\"554400000164224\" articlename=\"Holmes v. Wilkie, Nov 25 ,2019, 33 Vet.App. 67 (2020)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000164224/Holmes-v-Wilkie-Nov-25-2019-33-VetApp-67-2020\"><i>Holmes v. Wilkie</i></a>, 33 Vet.App. 67 (2020), held that the criteria of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>, contemplate more than merely headache symptoms, and that the DC requires VA to </span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">consider <i>all</i> symptoms experienced as a result of migraine attacks, and </span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">evaluate those symptoms based on the overall frequency, severity, and economic impact of the migraine attacks.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Example</i></b>:  A Veteran suffers SC migraine headaches that occur twice weekly and are prostrating in nature.  Symptoms manifested during the migraine headache attacks include frontal headaches, photophobia, nausea, and dizziness.  In evaluating the disability under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>, VA must consider all symptoms associated with the migraine headache attacks, and not just the headaches themselves.</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"height: 8px; width: 15px\"></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.b<a id=\"3b\" name=\"3b\">.</a>   DC 8100 Terminology:  Prostrating and Completely Prostrating</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Prostrating</em></strong>, as used in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>, means “causing extreme exhaustion, powerlessness, debilitation or incapacitation with substantial inability to engage in ordinary activities.” </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Completely prostrating</em></strong>, as used in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>, means extreme exhaustion or powerlessness with <em>essentially total</em> inability to engage in ordinary activities.  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.12.A.3.c<a id=\"3c\" name=\"3c\">.</a>  The Role of Medical Evidence in Establishing the Fact of Prostration</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Although prostration is substantially defined by how the disabled individual subjectively feels and functions when having migraine headache symptoms, medical evidence is required to establish that the reported symptoms are due to the SC migraine headaches. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The following is an example of a medical statement that would ordinarily establish the fact of prostration if the medical report and the history provided by the claimant are both credible.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em> </em></span></span></div><div style=\"margin-left: 40px\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em>The patient reports symptoms of severe head pain, blurred vision, nausea and vomiting, and being unable to tolerate light or noise, worsened by most activities including reading, writing, and engaging in conversations or physical activities.  When experiencing these symptoms, the patient only sleeps or rests.  The symptoms reported by the patient are consistent with the diagnosis of migraine headaches and the reported limitations are consistent with those seen in patients suffering from migraine headaches of similar clinical severity.  </em></span></span></div><div style=\"margin-left: 40px\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong><em> </em></strong></em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong><em>Note</em></strong></em>:  Medical reports may not use the word “prostration.”  However, this is an adjudicative determination based on the extent to which the facts meet the definition of the term. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.d<a id=\"3d\" name=\"3d\">.</a>  Lay Evidence of Prostration from Migraine Headaches</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">A claimant’s own testimony regarding symptoms <em>and</em> limitations when having those symptoms can establish prostration as long as the testimony is credible and symptoms are otherwise competently attributed to migraine headaches through medical evidence. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Example</em></strong>:  A claimant provides testimony that she 1) experiences severe headaches and vomiting when exposed to light; 2) does not engage in any activities when this occurs; and 3) must rest or sleep during these episodes.  If there is medical evidence that the claimant’s description of symptoms is in fact symptoms of migraine headaches, a determination that the headaches cause prostration can be made.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on competency of lay testimony, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000014389\" articlename=\"M21-1, Part V, Subpart ii, Chapter 1, Section B - Reviewing Testimony and Lay Evidence\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014389/M21-1-Part-V-Subpart-ii-Chapter-1-Section-B-Reviewing-Testimony-and-Lay-Evidence\">M21-1, Part V, Subpart ii, 1.B</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000073149\" articlename=\"Espiritu v. Derwinski, Jun 16, 1992, 2 Vet.App. 492 (1992)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000073149/Espiritu-v-Derwinski-Jun-16-1992-2-VetApp-492-1992\"><em>Espiritu v. Derwinski</em></a>, 2 Vet.App. 492 (1992).</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 78px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.e<a id=\"3e\" name=\"3e\">.</a>  DC 8100 Terminology: Severe Economic Inadaptability</span></span></h3></td><td style=\"height: 78px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 78px; width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Severe economic inadaptability</em></strong> denotes a degree of substantial work impairment.  It <em>does not</em> mean the individual is incapable of any substantially gainful employment.  Evidence of work impairment includes, but is not necessarily limited to, the use of sick leave or unpaid absence.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Note</em></strong>:  In cases where migraine headaches meet the criterion of severe economic inadaptability and, additionally, the evidence shows that the claimant is incapable of substantially gainful employment due to the headaches, referral for consideration of an extraschedular award of a total evaluation based on individual unemployability is appropriate.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on severe economic inadaptability, see <em><a articleid=\"554400000015346\" articlename=\"Pierce v. Principi, Oct 28, 2004, 18 Vet.App. 440\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015346/Pierce-v-Principi-Oct-28-2004-18-VetApp-440\">Pierce v. Principi</a></em>, 18 Vet.App 440 (2004).</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.f<a id=\"3f\" name=\"3f\">.</a>  DC 8100 Terminology: Less Frequent and Very Frequent</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a> does not define the terms <strong><em>less frequent</em></strong> for the 0- percent criterion or <strong><em>very frequent</em></strong> for the 50-percent criterion.  However, the overall rating criteria structure for migraine headaches provides a basis for guidance.</span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">As noted in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8100</a>, the 10-percent evaluation specifies average frequency (“averaging one in 2 months over the last several months”), which is half of what is required for a 30-percent evaluation (“on average once a month over the last several months”). </span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">For definitions of the terms <strong><em>less frequent</em></strong> and <strong><em>very frequent</em></strong>, refer to the table below.</span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 501px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a term-evaluation level-definition table.  Column 1 contains the term name, column 2 contains the evaluation level and column 3 contains the definition.\" width=\"501\"><thead><tr><th scope=\"col\" style=\"width: 114px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Term</strong></span></span></div></th><th scope=\"col\" style=\"width: 132px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Evaluation Level</strong></span></span></div></th><th scope=\"col\" style=\"width: 391px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Definition</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 114px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>less frequent</em></strong></span></span></div></td><td style=\"width: 132px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">0 percent</span></span></div></td><td style=\"width: 391px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">Characteristic prostrating attacks, on average, are more than two months apart over the last several months.</span></span></div></td></tr><tr><td style=\"width: 114px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>very frequent</em></strong></span></span></div></td><td style=\"width: 132px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">50 percent</span></span></div></td><td style=\"width: 391px; vertical-align: top; text-align: left; padding: 1px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">Characteristic prostrating attacks, on average, are less than one month apart over the last several months.</span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.12.A.3.g<a id=\"3g\" name=\"3g\">.</a>  Frequency Determinations:  Types of Proof</span></span></h3></td><td style=\"width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Frequency of migraine headache attacks or episodes is a factual determination.  Analyze all evidence in the record bearing on the question.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Probative evidence may include</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">medical progress notes</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">competent and credible lay evidence on how often the claimant experiences symptoms (as long as those symptoms have been competently identified as symptoms of migraine headaches)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">contemporaneous notes (a headache journal)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">prescription refills, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">witness statements.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Note</em></strong>:  The absence of treatment reports is not necessarily probative on the question of headache frequency as a claimant may not seek treatment for headaches during every episode.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluating evidence, including competency and credibility, see <a articleid=\"554400000014383\" articlename=\"M21-1, Part V, Subpart ii, Chapter 1, Section A - Principles of Reviewing and Weighing Evidence\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014383/M21-1-Part-V-Subpart-ii-Chapter-1-Section-A-Principles-of-Reviewing-and-Weighing-Evidence\">M21-1, Part V, Subpart ii, 1</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 191px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.12.A.3.h<a id=\"3h\" name=\"3h\">.</a>  Headache Journals</span></span></h3></td><td style=\"height: 191px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"height: 191px; width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Headache journals, which routinely and relatively contemporaneously record headache episodes, may be accepted as credible lay testimony regarding</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">headache frequency</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">prostration, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">occupational impairment (for example, sick leave due to headaches).</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Note</em></strong>:  Headaches recorded on non-work days may be used to prove frequency and prostration.  However, they will not generally be relevant to work availability, and performance or limitations, which are considerations in determining severe economic inadaptability.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180518\" articlename=\"M21-1, Part V, Subpart iii, Chapter 11 - Endocrine Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180518/M21-1-Part-V-Subpart-iii-Chapter-11-Endocrine-Conditions\">﻿﻿&lt;-- Previous Section</a>  <a articleid=\"554400000180832\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section B - Traumatic Brain Injury (TBI)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180832/M21-1-Part-V-Subpart-iii-Chapter-12-Section-B-Traumatic-Brain-Injury-TBI\">Next Section --&gt;</a></span></span></div><div class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></div><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://vbacoweba5.vba.va.gov/bl/21/DBQ/default.asp",
    "http://vbaw.vba.va.gov/bl/21/rating/rat00.htm",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=3cd0aebbeedd74c20521818b2c0b4cf5&mc=true&r=SECTION&n=se38.1.3_1303",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&r=SECTION&n=se38.1.4_1123",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&r=SECTION&n=se38.1.4_1124",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&r=SECTION&n=se38.1.4_1124a",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&node=se38.1.4_1123&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&node=se38.1.4_1124&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&node=se38.1.4_12&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=061a0b481382fdc4ff5c1697742e7858&node=se38.1.4_168&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=97036cf0c5662e736e138c4825800912&mc=true&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=993c22295f9daae770ddf81859d7bcab&mc=true&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=993c22295f9daae770ddf81859d7bcab&mc=true&node=se38.1.4_12&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=9f4321aacd8c092edc0248be8bca1242&mc=true&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&node=se38.1.4_11&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&node=se38.1.4_1120&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c57cdeff39f8794ce53822404bf19c6c&mc=true&node=se38.1.4_121&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&node=se38.1.3_1309&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&node=se38.1.4_1121&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&node=se38.1.4_1122&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f0aa74b3307a3ad4b8794ead73ecfa75&node=se38.1.4_1124a&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=7bb77fadaa9b6f28b29ee834697f0824&mc=true&r=SECTION&n=se38.1.3_1307",
    "https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=7bb77fadaa9b6f28b29ee834697f0824&mc=true&r=SECTION&n=se38.1.3_1309",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=1b4e99c4e9c6fe666246fbc96c1486b3&mc=true&node=se38.1.4_155&rgn=div8",
    "https://www.ecfr.gov/current/title-38/section-4.124a"
  ],
  "scraped_at": "2025-06-16T22:46:03.175696",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180832/M21-1-Part-V-Subpart-iii-Chapter-12-Section-B-Traumatic-Brain-Injury-TBI"
}